These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 32247288)

  • 1. Compounded preparations in dermatology - analysis of prescribing habits in everyday clinical practice in Germany.
    Salzmann S; Salzmann M; Staubach P
    J Dtsch Dermatol Ges; 2020 Apr; 18(4):334-340. PubMed ID: 32247288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of Topical Corticosteroid Prescribing, Counseling, and Communication Among Dermatologists and Pharmacists.
    Millard AN; Stratman EJ
    JAMA Dermatol; 2019 Jul; 155(7):838-843. PubMed ID: 30916731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence, determinants, and characteristics of extemporaneous compounding in Jordanian pharmacies.
    AlKhatib HS; Jalouqa S; Maraqa N; Ratka A; Elayeh E; Al Muhaissen S
    BMC Health Serv Res; 2019 Nov; 19(1):816. PubMed ID: 31703672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prescribing Patterns for Atopic Dermatitis in the United States.
    Pona A; Cline A; Kolli S; Feldman SF; Fleischer AFJ
    J Drugs Dermatol; 2019 Oct; 18(10):987-990. PubMed ID: 31584776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of Extemporaneous Prescriptions Prescribed by Dermatovenerologists in Latvia and Comparison with Standardized Compounded Preparation Monographs of Germany and USA.
    Kiseļova O; Mauriņa B; Šidlovska V
    Medicina (Kaunas); 2020 Jan; 56(1):. PubMed ID: 31936697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of in-office samples on dermatologists' prescribing habits: a retrospective review.
    DeNigris J; Malachowski SJ; Miladinović B; Nelson CG; Patel NS
    Cutis; 2020 Jan; 105(1):E24-E28. PubMed ID: 32074163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pattern of topical corticosteroid prescribing in the United States, 1989-1991.
    Stern RS
    J Am Acad Dermatol; 1996 Aug; 35(2 Pt 1):183-6. PubMed ID: 8708016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extemporaneous formulations in Germany - relevance for everyday clinical practice.
    Staubach P; Salzmann S; Peveling-Oberhag A; Weyer V; Zimmer S; Gradl G; Lang BM
    J Dtsch Dermatol Ges; 2018 May; 16(5):566-574. PubMed ID: 29750454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants and frequency of pharmaceutical compounding in pharmacy practice in Palestine.
    Zaid AN; Al-Ramahi R; Shahed Q; Saleh B; Elaraj J
    Int J Pharm Pract; 2012 Feb; 20(1):9-14. PubMed ID: 22236175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sense and nonsense of extemporaneous formulations].
    Staubach P
    Hautarzt; 2014 Mar; 65(3):180-5. PubMed ID: 24424730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid Prescribing Patterns and Complications in the Dermatology Medicare Population.
    Cao S; Karmouta R; Li DG; Din RS; Mostaghimi A
    JAMA Dermatol; 2018 Mar; 154(3):317-322. PubMed ID: 29417134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physician perspectives in the management of psoriasis and psoriatic arthritis: results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis survey.
    van de Kerkhof PC; Reich K; Kavanaugh A; Bachelez H; Barker J; Girolomoni G; Langley RG; Paul CF; Puig L; Lebwohl MG
    J Eur Acad Dermatol Venereol; 2015 Oct; 29(10):2002-10. PubMed ID: 25885420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical preparations and their use in dermatology.
    Wohlrab J
    J Dtsch Dermatol Ges; 2016 Nov; 14(11):1061-1070. PubMed ID: 27879084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dermatologists and allergists have far more experience and use more complex treatment regimens in the treatment of atopic dermatitis than other physicians.
    Henderson RL; Fleischer AB; Feldman SR
    J Cutan Med Surg; 2001; 5(3):211-6. PubMed ID: 11685667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of prescribing isotretinoin: focus on women of childbearing potential.
    Doering PL; Araujo OE; Frohnapple DJ; LaMarre AS; Flowers FP
    Ann Pharmacother; 1992 Feb; 26(2):155-61. PubMed ID: 1554922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dermoscopy use by Canadian dermatologists and dermatology residents: a cross-sectional nationwide study.
    Burbidge T; Davidson W; Robertson L
    Br J Dermatol; 2017 Nov; 177(5):e213-e214. PubMed ID: 28449184
    [No Abstract]   [Full Text] [Related]  

  • 17. The Practice of Compounding, Associated Compounding Regulations, and the Impact on Dermatologists.
    Quertermous J; Desai S; Harper J; Lebwohl M; Torres A; Kircik LH
    J Drugs Dermatol; 2018 Jul; 17(7):s17-s22. PubMed ID: 30005109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of vitiligo. Results of a questionnaire among dermatologists in The Netherlands.
    Njoo MD; Bossuyt PM; Westerhof W
    Int J Dermatol; 1999 Nov; 38(11):866-72. PubMed ID: 10583624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psoriasis Area and Severity Index (PASI) revisited: A survey on current impression and practice in New Zealand.
    Huang C; Chan BCY
    Australas J Dermatol; 2020 Nov; 61(4):e486-e487. PubMed ID: 32757271
    [No Abstract]   [Full Text] [Related]  

  • 20. S2k guidelines for the use of topical preparations on the skin.
    Wohlrab J; Staubach P; Augustin M; Eisert L; Hünerbein A; Nast A; Reimann H; Strömer K; Mahler V
    J Dtsch Dermatol Ges; 2018 Mar; 16(3):376-392. PubMed ID: 29537159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.